Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Long-Term Investments: 2015-2024

Historic Long-Term Investments for Cartesian Therapeutics (RNAC) over the last 9 years, with Dec 2024 value amounting to $2.0 million.

  • Cartesian Therapeutics' Long-Term Investments changed negligibly% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Cartesian Therapeutics' Long-Term Investments is $2.0 million, which was down 0.00% from $2.0 million recorded in FY2023.
  • In the past 5 years, Cartesian Therapeutics' Long-Term Investments registered a high of $2.0 million during FY2021, and its lowest value of $2.0 million during FY2021.
  • Moreover, its 3-year median value for Long-Term Investments was $2.0 million (2024), whereas its average is $2.0 million.